Stanford physician-scientist | Infectious diseases, epidemiology, modeling, and public health | Views mine | Lo Lab: http://profiles.stanford.edu/nathan-lo
Nathan Lo
Loading...
ID fellows: Join us for the next virtual Fellows Case Conference on Monday, June 15 at 2pm ET. Explore a unique ID case alongside presenters Jonathan Huang, MD, and Melissa Kerkelis, MD, with faculty discussants Alex Zimmet, MD, and Courtney Harris, MD.
Register: https://bit.ly/3RQmozx
www.science.org/content/arti...
This #Ebola outbreak has quickly become alarmingly large & will be very hard to contain. But only the 3rd outbreak of the Bundibugyo Ebola virus, it presents a rare opportunity to study this virus, @kakape.bsky.social reports. www.science.org/content/arti...
Ebola in the Democratic Republic of the Congo and Uganda determined a public health emergency of international concern by WHO
www.who.int/news/item/17...
"...most introductions end in rapid stochastic extinction, making sustained transmission unlikely despite the risk of localised superspreading events in higher-risk environments, such as crowded indoor spaces."
www.thelancet.com/journals/lan...
Thrilled to be elected as a Fellow of the Infectious Diseases Society of America!
Thrilled to receive the Rosenkranz Prize for our work in neglected tropical diseases and global health!
healthpolicy.fsi.stanford.edu/news/rosenkr...
A hantavirus outbreak on a cruise ship has never been documented—the virus does not usually spread from person to person—and the incident has raised a series of challenges that researchers from around the world are teaming up to solve. https://scim.ag/4tSGaIP
Stanford Medicine researchers are rethinking how to fight viruses by targeting the human cells they rely on. This “home turf” approach could lead to treatments that work against a wide range of viral threats. med.stanford.edu/news/insight...
Testing, sequencing, and clinical trial efforts spring to life as Bundibugyo virus spreads
After weeks of NIAID, the NIH's second largest institute, being in a leadership vacuum following Jeffrey Taubenberger stepping down, it has a new director: John H. Powers III
www.statnews.com/2026/06/09/n...
The Bundibugyo virus only emerged twice before. Now, scientists see a chance to get to know it better
Pursuant to paragraph 2 of Article 12 - Determination of a public health emergency of international concern, including a pandemic emergency of the International Health Regulations (2005) (IHR), the Di...
Hantavirus pulmonary syndrome is a severe respiratory disease with a case-fatality
rate historically exceeding 30%.1 Although most hantaviruses are primarily transmitted
via the inhalation of aerosoli...
Questions about the culprit virus and its route of spread remain as health officials make plans for stranded passengers
www.science.org
The emergence of a nasty new virus or even an unexpected flu strain can pose a big public-health headache. Meanwhile, antiviral drug development moves at an agonizingly slow pace and cringingly high c...
The NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.
IDSA is pleased to welcome the 166 individuals chosen to receive a FIDSA designation, a prestigious honor recognizing distinguished infectious diseases clinicians and scientists from around the world.
View our web release and this year’s inductees: https://bit.ly/42RzzlR
